BridgeMD
Tests treatment safety and results for Hypertension
Official title Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
ClinicalTrials.gov ID: NCT07090161
What this study is testing
What is iloperidone?
iloperidone is an investigational medicine, being studied as a potential treatment for hypertension.
Also referred to as Fanapt.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Iloperidone for the Treatment of Participants with Uncontrolled Hypertension
- Phase 2: a mid-size study of how well it works
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- SiSBP \>/= 130 mmHg despite \>8 weeks treatment w/ 1 or more antihypertensive therapies
You likely can't join if
- Confirmed Grade 3/severe hypertension (SiSBP \>/= 180 mmHg, SiDBP \>/= 120 mmHg), unstable cardiac disease, renal insufficiency
The study team makes the final eligibility decision.
Where it's taking place
- Phoenix, Arizona, United States
- Tempe, Arizona, United States
- Tucson, Arizona, United States
- Chula Vista, California, United States
- Dublin, California, United States
- Valencia, California, United States
- Walnut Creek, California, United States
- Doral, Florida, United States
- Fort Myers, Florida, United States
- Columbus, Georgia, United States
- Oak Brook, Illinois, United States
- Tinley Park, Illinois, United States
- El Dorado, Kansas, United States
- Wichita, Kansas, United States
- Lexington, Kentucky, United States
- Hazelwood, Missouri, United States
- Las Vegas, Nevada, United States
- Mount Kisco, New York, United States
- Rochester, New York, United States
- Kinston, North Carolina, United States
+ 8 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Phoenix, Arizona, United States; Tempe, Arizona, United States; Tucson, Arizona, United States; Chula Vista, California, United States; Dublin, California, United States; Valencia, California, United States and 22 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.